Alerts will be sent to your verified email
Verify Email
STRATMONT
|
Stratmont Industries
|
Balaxi Pharma.
|
Shradha AI Tech.
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
13.87 % | 27.3 % | 8.06 % |
|
5yr Avg Net Profit Margin
|
1.4 % | 11.03 % | 38.54 % |
|
Price to Book
|
8.74 | 1.09 | 2.78 |
|
P/E
|
191.52 | 13.39 | 25.17 |
|
5yr Avg Cash Conversion Cycle
|
92.3 Days | 154.28 Days | 47.93 Days |
|
5yr Average Interest Coverage Ratio
|
366.2 | 57.05 | 638.09 |
|
5yr Avg ROCE
|
19.96 % | 36.52 % | 10.4 % |
|
5yr Avg Operating Profit Margin
|
-11.43 % | 16.64 % | 35.27 % |
|
5 yr average Debt to Equity
|
2.19 | 0.09 | 0.0 |
|
5yr CAGR Net Profit
|
153.17 % | -5.76 % | 68.38 % |
|
5yr Average Return on Assets
|
4.02 % | 18.47 % | 7.4 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
67.58 % | 65.99 % | 74.66 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
3.04 % | -6.87 % | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
-0.22 % | 0.0 | 0.0 |
|
Stratmont Industries
|
Balaxi Pharma.
|
Shradha AI Tech.
|
|---|